North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032

Overview

The North America Alpha and Beta Emitters Based Radiopharmaceuticals Market is expected to reach a 783.53 USD Million by 2032 and is projected to grow at a CAGR of 11.07% from 2025 to 2032.

Revenue, 2024 (USD Million)

339.33

Forecast, 2032 (USD Million)

783.53

CAGR, 2024 - 2032

11.07%

Report Coverage

North America

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market 2018-2032 USD Million

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 339.33 USD Million
Projected Market Size (2032): 783.53 USD Million
CAGR (2025-2032): 11.07%

Key Findings of North America Alpha and Beta Emitters Based Radiopharmaceuticals Market

The North America Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at 339.33 USD Million in 2024.
The North America Alpha and Beta Emitters Based Radiopharmaceuticals Market is likely to grow at a CAGR of 11.07% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Beta Emitters in Isotope Segment accounted for the largest share of the market with a revenue of 283.91 USD Million
The fastest growing segment Small Molecule Ligands in Vector Type Segment grew Fastest with a CAGR of 11.74% during the forecast period from 2024 to 2032.

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Scope

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Segmentation & Scope

Isotope

Alpha Emitters
Beta Emitters

Vector Type

Others
Monoclonal Antibodies
Peptides
Small Molecule Ligands

End User

Research Institutes
Radiopharmacies
Hospitals

Sources

Others
Generator-Produced Isotopes
Reactor-Produced Isotopes

Therapeutic Application

Others
Oncology

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Data Coverage Insights

Study Period	2024-2032
Base Year	2024
Unit	Revenue in USD Million
Market Value in 2024	339.33 USD Million
Market Value in 2032	783.53 USD Million
CAGR (2025-2032)	11.07%
Historic Data	2016-2023
Market Segments Covered	Isotope,Vector Type,End User,Sources,Therapeutic Application

Regional Insights:

Leading Market (2024-2032): North America, leading in terms of revenue 339.33 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 148.50 USD Million in 2024.

Segments and Scope

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Isotope
- Beta Emitters is the largest segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 283.91 USD Million in the year 2024.
- Beta Emitters is the Fastest growing segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 11.11 % in forecast period 2025-2032.
North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Vector Type
- Small Molecule Ligands is the largest segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 170.14 USD Million in the year 2024.
- Small Molecule Ligands is the Fastest growing segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 11.74 % in forecast period 2025-2032.
North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 188.29 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 11.22 % in forecast period 2025-2032.
North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Sources
- Reactor-Produced Isotopes is the largest segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 206.04 USD Million in the year 2024.
- Reactor-Produced Isotopes is the Fastest growing segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 11.21 % in forecast period 2025-2032.
North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Therapeutic Application
- Oncology is the largest segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 258.56 USD Million in the year 2024.
- Oncology is the Fastest growing segment in North America Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 11.44 % in forecast period 2025-2032.

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Share Analysis

Company Name
Novartis AG
Eckert & Ziegler
ITM Isotope Technologies Munich SE
SHINE Technologies, LLC

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Million

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market

Middle East & Africa Cold Sore Treatment Market

North America Cold Sore Treatment Market

Europe Cold Sore Treatment Market

Asia-Pacific Cold Sore Treatment Market

Argentina Cold Sore Treatment Market

Australia Cold Sore Treatment Market

Austria Cold Sore Treatment Market

Belgium Cold Sore Treatment Market

Brazil Cold Sore Treatment Market

Frequently Asked Questions

What are the primary segments covered in the North America Alpha and Beta Emitters Based Radiopharmaceuticals Market?

The North America Alpha and Beta Emitters Based Radiopharmaceuticals Market is segmented based on Segmentation Isotope,Vector Type,End User,Sources,Therapeutic Application.

What is the current market size of the North America Alpha and Beta Emitters Based Radiopharmaceuticals Market?

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at USD 339.33(Revenue in USD Million) in 2024.

What is the expected growth rate of the North America Alpha and Beta Emitters Based Radiopharmaceuticals Market?

North America Alpha and Beta Emitters Based Radiopharmaceuticals Market is projected to grow at a CAGR of 11.07% during the forecast period of 2024 to 2032.

Which is the dominating segment in the North America Alpha and Beta Emitters Based Radiopharmaceuticals Market?

The Beta Emitters segment is expected to dominate the North America Alpha and Beta Emitters Based Radiopharmaceuticals Market, holding a largest market share of 283.91 USD Million in 2024